There is a growing body of evidence suggesting that loss of E-cadherin expression or mutation in the E-cadherin gene may have a pivotal role in tumour progression as marked by increased mobility and invasiveness in various types of cancers, including bladder cancer (Birchmeier and Behrens, 1994; Imao et al, 1999). This evidence concerns the gene CDH1 and neoplasm.